New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis, The Scripps Research Institute, Howard Hughes Medical Institute, and Albert Einstein College of Medicine Study

Published: Jun 18, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news